ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline
Business Wire India At ASDS 2025, Galderma unveiled pivotal new data from its range of pioneering Restylane® hyaluronic acid…
